Back to Search

LILIA WOJCIK, MD

MD

Anatomic Pathology & Clinical Pathology Physician

NPI: 1043280126IndividualAccepts Medicare

Specialties, Licenses & Credentials

Anatomic Pathology & Clinical Pathology PhysicianPrimary

Pathology — Anatomic Pathology & Clinical Pathology

Code: 207ZP0102X

H7042(TX)

CMS Specialties

PrimaryPATHOLOGY

Education

OTHER

Class of 1981

Research & Publications (11)

Neurogenesis in gerbil hippocampus following brain ischemia: focus on the involvement of metalloproteinases.
PMID 19325641·Acta Neurobiol Exp (Wars)·2009
7-preclinical
Acute effects of localized muscle fatigue on postural control and patterns of recovery during upright stance: influence of fatigue location and age.
PMID 19306019·Eur J Appl Physiol·2009
8-other
Effects of localized muscle fatigue on recovery from a postural perturbation without stepping.
PMID 19168359·Gait Posture·2009
8-other
Mapping resistance to the CCR5 co-receptor antagonist vicriviroc using heterologous chimeric HIV-1 envelope genes reveals key determinants in the C2-V5 domain of gp120.
PMID 18190945·Virology·2008
8-other
The influence of age on isometric endurance and fatigue is muscle dependent: a study of shoulder abduction and torso extension.
PMID 17178650·Ergonomics·2007
8-other
Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1.
PMID 16304152·Antimicrob Agents Chemother·2005
8-other
New particle-loaded monoliths for chiral capillary electrochromatographic separation.
PMID 15472965·Electrophoresis·2004
8-other
HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use.
PMID 11782552·Proc Natl Acad Sci U S A·2002
8-other
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo.
PMID 11606733·Proc Natl Acad Sci U S A·2001
7-preclinical
Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoromethyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-oxide (Sch-350634), an orally bioavailable, potent CCR5 antagonist.
PMID 11585438·J Med Chem·2001
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
3300 NACOGDOCHES RD, SUITE 110
SAN ANTONIO, TX 78217

Quick Facts

NPI
1043280126
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
45
Publications
11

Are you this provider?

Claim Your Profile